FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2025
Voltar para busca
Dado oficial do USPTO
ALGENSCRIBE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ALGENSCRIBE
ST13
US500000079374320Classe
1, 5, 42, 44
Pedido
79374320
Registro
7424131
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
07/04/2023
Data de registro
25/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/06/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
FR
Examinador
FLEMING, STEPHANIE
Unidade examinadora
N40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ALGENSCRIBE
Representantes
Cathleen E. Stadecker Downs Rachlin Martin PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemicalbiotechnological products intended for use in industryscienceagriculturehorticulturechemical and biochemical preparations for scientific purposeschemicals for use in biotechnological product developmentchemicals and biochemicals used in industry; Chemicalbiochemicalbiotechnological and bacteriological products for use in research and testing laboratorieschemical and biochemical preparations for research purposeschemicals for use in biotechnological product developmentother than for medical or veterinary purposes; Chemical and biochemical preparations used in the manufacture of pharmaceuticals; Biotechnological products used in the manufacture of pharmaceuticalschemicals for use in biotechnological product development; Chemical preparations used for the production of gene and cell therapies; Diagnostic preparations other than for medical use; Diagnostic reagents and preparations for scientific use; Diagnostic reagents and preparations for scientific laboratories; Reagents for analytical usechemical analysis reagents other than for medical or veterinary purposes; Reagents for the extractionpreservation and processing of humananimalplant or microbiological samples for collecting genetic or genomic information other than for medical or veterinary purposes; Diagnostic testing preparationsreagents and assays for scientific use
Classe 5
Veterinary and pharmaceutical preparationsgene-based and cell-based therapeutic preparations for treating cancer; Pharmaceutical preparations for gene and cell therapy; Biological preparations for use in gene therapy and cell therapy for medical purposes; Micro-organism cultures and preparations for medicalpharmaceutical and/or veterinary use; Bacteriological preparations for medicalpharmaceutical and/or veterinary use; Diagnostic reagents and preparations for clinicalmedicalpharmaceutical and/or veterinary use; Diagnostic test preparations consisting principally of reagents and assays for clinicalmedicalpharmaceutical and/or veterinary use
Classe 42
Scientific and industrial researchchemical researchresearch and development of new biological and medical products; Scientific geneticmedicalpharmaceutical and veterinary research; Scientific geneticmedicalpharmaceutical and veterinary researchresearch in the field of pharmaceutical preparations for gene and cell therapy; Research in chemistrybiologybiochemistrymolecular biology; Scientific research in the field of biologygenetics and genomics; Scientific research services using genomic analysis procedures; Biologicalscientific genetic and genomic handling and analysis services for scientific use; Structural and functional genome analysisfor scientific purposes; Biotechnological research and development for third partiesincluding scientific feasibility studies on genetic associationsgenome mappinggenome analysis and genome scanning; Scientific analysis in the field of genetics and genomics; Scientific research and development of biochemical analysisbiological analysis and molecular biology techniques; Research and development of new molecules intended for use in industrypreparing and providing biological materials and particularly stem cells; Developing pharmaceutical drugs and therapeutics; Scientific laboratory servicesbiological material modifications
Classe 44
Medical diagnostic servicesincluding diagnostic and reagent sample testing services for third parties; Genetic testing for medical purposesincluding genome mappinggenome analysis and genome scanning; Biologicalgenetic and genomic handling and analysis services for medical use; Medical genetic or genomic testing for detecting risksdiagnosing illness or selecting treatment in humansanimals or plants
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
21/02/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2025
FIMP
FINAL DISPOSITION PROCESSED
13/02/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/01/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
25/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
16/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/04/2024
PUBO
PUBLISHED FOR OPPOSITION
09/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2024
RFNT
REFUSAL PROCESSED BY IB
19/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/01/2024
RFRR
REFUSAL PROCESSED BY MPU
29/01/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2024
CNRT
NON-FINAL ACTION WRITTEN
11/01/2024
DOCK
ASSIGNED TO EXAMINER
04/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
21/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALGENSCRIBE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.